Skip to main content

Table 1 Demographic and clinical data of patients and controls

From: An antibody microarray analysis of serum cytokines in neurodegenerative Parkinsonian syndromes

A. Screening cohort analyzed in cytokine microarray experiment

 

PSP/CBS

MSA

PD

CTRL

p-value

Number

10

10

20

30

 

Female, n(%)

6(60)

6(60)

12(60)

18(60)

nsb

Age, ya

68(54–75)

66(54–75)

67(52–81)

65(56–80)

nsc

Duration, ya

4(1–8)

5(1–9)

6(1–37)

 

nsc

Hoehn&Yahra

3(2–5)

4(2–5)

2(1–4)

 

<0.001c

Dementia, n(%)

3(30)

2(20)

2(10)

 

nsb

Treatment, n(%)

9(90)

5(50)

18(90)

 

ns

 

PSP/CBS

MSA

PD

CTRL

p-value

Number

28

21

97

69

 

Female, n(%)

14(50)

14(67)

32(33)

29(42)

0.03b

Age, ya

74(57–84)

63(46–78)

66(41–85)

63(42–93)

<0.001c

Duration, ya

3(1–11)

3(1–6)

4(0–27)

 

nsc

Hoehn&Yahra

4(2–5)

4(0–5)

2(0–5)

 

<0.001c

Dementia, n(%)

14(52)

0(0)

10(11)

 

<0.001b

Treatment, n(%)

19(68)

15(71)

63(65)

 

nsb

  1. y = years, ns = not statistically significant, treatment = patients treated with levodopa and/or dopamine agonists and/or monoamine oxidase inhibitors
  2. a data are shown as median (range), p-value: groups were compared using b Chi-Square test and c Kruskal-Wallis test.